The Finished Dosage Formulations (FDF) market in India is currently undergoing an exhilarating metamorphosis, propelled by a kaleidoscope of dynamic forces. A mosaic of influences converges to catalyze this remarkable growth: surging healthcare demands, an alarming uptick in chronic ailments, and revolutionary breakthroughs in pharmaceutical technology. Gazing into the horizon of 2025, projections illuminate a market poised for a vigorous valuation, reflecting a robust CAGR that signifies relentless vitality. At the nucleus of this expansion lies the enhanced accessibility to healthcare... >>More
Dheeraj Jain, Founder, Redcliffe Labs
Surabhi Loshali, Group Chief Human Resources Officer, Strides
Dr. Paromita Kanjilal, Consultant - Emergency Medicine, Manipal Hospitals
Dr. Kapil Maithal, President, Vaccines & Diagnostics - R&D & Technical Operations, Zydus Lifesciences
Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre